Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$170.78 - $208.42 $1.11 Million - $1.35 Million
6,498 New
6,498 $1.2 Million
Q2 2023

Oct 21, 2024

BUY
$138.42 - $180.31 $7.5 Million - $9.76 Million
54,155 New
54,155 $7.66 Million
Q2 2023

Aug 07, 2023

BUY
$138.42 - $180.31 $7.5 Million - $9.76 Million
54,155 New
54,155 $7.66 Million
Q3 2022

Nov 07, 2022

SELL
$160.42 - $256.21 $18,769 - $29,976
-117 Reduced 4.17%
2,691 $504,000
Q2 2022

Aug 09, 2022

SELL
$140.68 - $188.02 $1.05 Million - $1.41 Million
-7,489 Reduced 72.73%
2,808 $456,000
Q1 2022

May 12, 2022

BUY
$161.19 - $257.96 $1.3 Million - $2.08 Million
8,054 Added 359.07%
10,297 $1.94 Million
Q4 2021

Feb 10, 2022

BUY
$247.59 - $304.47 $555,344 - $682,926
2,243 New
2,243 $594,000
Q4 2020

Feb 12, 2021

SELL
$148.08 - $206.57 $589,950 - $822,974
-3,984 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$122.51 - $158.27 $488,079 - $630,547
3,984 New
3,984 $588,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.99B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.